Pulmonary vein isolation and additional selective ablation of low voltage areas and atrial late potentials for persistent atrial fibrillation (SOLVE-AF-Study)

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private company. Main funding source(s): Abbott INTRODUCTION: Novel catheter ablation technologies (e.g. RF with contiguous lesions) for pulmonary vein isolation (PVI) achieve high (80-85%) arrhythmia freedom rates at 12 months in both paroxysmal an...

Descripción completa

Detalles Bibliográficos
Autores principales: Jadidi, A, Mueller-Edenborn, B, Eichenlaub, M, Lehrmann, H, Allgeier, J, Trenk, D, Neumann, F, Westermann, D, Arentz, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
10.4.5 - Rhythm Control, Catheter Ablation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207252/
http://dx.doi.org/10.1093/europace/euad122.135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207252/
http://dx.doi.org/10.1093/europace/euad122.135

Ejemplares similares